Novel antibiotics from DNA adenine methyltransferase inhibitors

DNA adenine methylation plays a role in several core bacterial processes, including DNA mismatch repair, the timing of DNA replication and gene expression. The dependence of bacterial virulence on the activity of Dam, an adenine methyltransferase, makes it an attractive target for novel antibiotics....

Full description

Bibliographic Details
Main Author: Maynard-Smith, Michael David
Other Authors: Roach, Peter
Published: University of Southampton 2009
Subjects:
540
Online Access:https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.548212
id ndltd-bl.uk-oai-ethos.bl.uk-548212
record_format oai_dc
spelling ndltd-bl.uk-oai-ethos.bl.uk-5482122018-09-05T03:28:52ZNovel antibiotics from DNA adenine methyltransferase inhibitorsMaynard-Smith, Michael DavidRoach, Peter2009DNA adenine methylation plays a role in several core bacterial processes, including DNA mismatch repair, the timing of DNA replication and gene expression. The dependence of bacterial virulence on the activity of Dam, an adenine methyltransferase, makes it an attractive target for novel antibiotics. Dam from Yersinia pestis, the plague causing bacteria, was expressed and purified by nickel affinity chromatography. A plasmid containing the methylation sensitive restriction endonuclease dpnI gene was assembled. DpnI was expressed and purified by nickel affinity chromatography. A Y. pestis Dam activity assay, which relied on the sensitivity of DpnI to DNA methylation, was developed. This continuous fluorescence based assay was used to determine several kinetic parameters of the enzyme. The assay was validated for use in a high throughput 96-well format and used to screen a library of one thousand compounds for Y. pestis Dam inhibitors. Several compounds of interest were identified. These compounds were synthesised, re-tested for activity against Dam, counter- screened against the restriction endonuclease DpnI and assayed for an ability to bind DNA. A plasmid encoding Dam from the hyperthermophile Pyrococcus horikoshii was assembled. Wild type P. horikoshii Dam was expressed and purified by nickel affinity chromatography. The resultant Dam was contaminated by a product of mis-initiation of translation at an internal methionine codon. Site directed mutagenesis was undertaken to replace the problematic codon in the dam gene. Mutant P. horikoshii Dam was expressed and purified by nickel affinity chromatography. This hyperthermophilic enzyme was used in the development of a direct and continuous fluorescence based assay for Dam activity. Several kinetic parameters of P. horikoshii Dam were determined with the direct assay540QD ChemistryUniversity of Southamptonhttps://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.548212https://eprints.soton.ac.uk/202481/Electronic Thesis or Dissertation
collection NDLTD
sources NDLTD
topic 540
QD Chemistry
spellingShingle 540
QD Chemistry
Maynard-Smith, Michael David
Novel antibiotics from DNA adenine methyltransferase inhibitors
description DNA adenine methylation plays a role in several core bacterial processes, including DNA mismatch repair, the timing of DNA replication and gene expression. The dependence of bacterial virulence on the activity of Dam, an adenine methyltransferase, makes it an attractive target for novel antibiotics. Dam from Yersinia pestis, the plague causing bacteria, was expressed and purified by nickel affinity chromatography. A plasmid containing the methylation sensitive restriction endonuclease dpnI gene was assembled. DpnI was expressed and purified by nickel affinity chromatography. A Y. pestis Dam activity assay, which relied on the sensitivity of DpnI to DNA methylation, was developed. This continuous fluorescence based assay was used to determine several kinetic parameters of the enzyme. The assay was validated for use in a high throughput 96-well format and used to screen a library of one thousand compounds for Y. pestis Dam inhibitors. Several compounds of interest were identified. These compounds were synthesised, re-tested for activity against Dam, counter- screened against the restriction endonuclease DpnI and assayed for an ability to bind DNA. A plasmid encoding Dam from the hyperthermophile Pyrococcus horikoshii was assembled. Wild type P. horikoshii Dam was expressed and purified by nickel affinity chromatography. The resultant Dam was contaminated by a product of mis-initiation of translation at an internal methionine codon. Site directed mutagenesis was undertaken to replace the problematic codon in the dam gene. Mutant P. horikoshii Dam was expressed and purified by nickel affinity chromatography. This hyperthermophilic enzyme was used in the development of a direct and continuous fluorescence based assay for Dam activity. Several kinetic parameters of P. horikoshii Dam were determined with the direct assay
author2 Roach, Peter
author_facet Roach, Peter
Maynard-Smith, Michael David
author Maynard-Smith, Michael David
author_sort Maynard-Smith, Michael David
title Novel antibiotics from DNA adenine methyltransferase inhibitors
title_short Novel antibiotics from DNA adenine methyltransferase inhibitors
title_full Novel antibiotics from DNA adenine methyltransferase inhibitors
title_fullStr Novel antibiotics from DNA adenine methyltransferase inhibitors
title_full_unstemmed Novel antibiotics from DNA adenine methyltransferase inhibitors
title_sort novel antibiotics from dna adenine methyltransferase inhibitors
publisher University of Southampton
publishDate 2009
url https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.548212
work_keys_str_mv AT maynardsmithmichaeldavid novelantibioticsfromdnaadeninemethyltransferaseinhibitors
_version_ 1718730041744949248